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Purpose
To evaluate the efficacy of MR guided acoustic ablation
in symptoms relief and volume reduction over time.
Materials and method
110 leiomyomas in 98 women (average age 39,3 years)
were treated with MRI-guided focused ultrasound
(MRgFUS). The treatment is carried out using the abla-
tive properties of the HIFU system under 3T MRI
guide. Symptoms (e.g. menorrhagia, pelvic pain) were
scored using Severity Score (SS) and quality of life was
determined using the UFS-QOL score. Pre-treatment
measurementes of leiomyoma volume were obtained by
MR images. Immediately after treatment, Non-perfused
Volume (NPV) was calculated from T1-w contrast-
enhanced MR sequences. The average volume of treated
fibroids was 90.27 ± 90.4 mm3. Follow-up images were
obtained at 3 and 12 months after treatment and served
to determine leiomyoma shrinkage. Qualitative and
quantitative relations between fibroid volume, NPV ratio
at treatment, and 12-month shrinkage were measured.
Results
MRgFUS treated patients demonstrated a significant
change in USF-QoL score: mean SS score values were
48.6 ± 13.4 (pre-treatment), 25.1 ± 8.9 (three-months
follow-up) and 19,3± 6.8 (twelve-months follow-up).
Fibroids volume changed from 90.27±90.4 mm3 (before
treatment) to 54 ± 66.1 mm3 (at 12 months follow up).
We encountered a statistically significant difference
between the two values (p = 0.001). Mean post-treat-
ment VNP was 57,65±52.9 mm3, about 63% of total
fibroid volume (p=0.001).
Conclusion
MRgFUS therapy of leyomioma results in a significant
relief of symptoms and greater than 50% total fibroid
ablation. The procedure is carried out in a totally non-
invasive manner and features a high safety profile.
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